Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 45
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II-III Therapy with 5-FU vs 5-FU/TZT vs 5-FU/ICRF-159 vs MeCCNU/ICRF-159 vs MeCCNU/TZT vs ICRF-159/TZT for Advanced Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
NCI
NCCTG-784651
Last Modified:
4/12/2006
2.
Phase II/III Chemotherapy with FAP (5-FU/ADR/CACP) vs FAT (5-FU/ADR/TZT) vs FAMe (5-FU/ADR/MeCCNU) in Metastatic or Unexplored Gastric Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
GITSG-8380
Last Modified:
7/1/1990
3.
Phase II/III Combination Chemotherapy with FAME (5-FU/ADR/MeCCNU) vs FAP (5-FU/ADR/CACP) vs FAME Alternating with TZT vs 5-FU Alone for Advanced Gastric Carcinoma (Summary Last Modified 07/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
18 and over
NCI
NCCTG-834151
MAYO-834151, NCCTG-83-41-51
4.
Phase II-III Chemotherapy with Ftorafur vs 5-FU/MeCCNU/TZT vs 5-FU/MeCCNU/ICRF-159 vs 5-FU/MeCCNU/VCR for Advanced Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
MAYO-764802
Last Modified:
4/1/1988
5.
Phase I/II Pilot Study of Chemotherapy with MITOC/TZT/CDDP in Patients with Advanced Gastrointestinal Cancer (Summary Last Modified 04/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
NCI
MAYO-860302
NCI-T86-0204H, T86-0204
6.
Phase I-II Chemotherapy with CTX, ADR, DAG, VP-16, PZD and TZT for Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
no age specified
MAYO-750302
7.
Phase I/II Optimal Dose Level Pilot Study of 5-FU, ICRF-159, MeCCNU plus Triazinate in Various Two-Drug Combinations for Large Bowel Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
no age specified
MAYO-770304
8.
Phase II Chemotherapy with TZT for Metastatic Cancer of Breast, Lung, Head & Neck, GI Tract, Genitourinary System, and Gynecologic System
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI-D78-048-054
WCCC-CO-7792
9.
Phase II Chemotherapy with Baker's Antifol for Leukemia or Solid Tumors in Children
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
under 21
NCI
POG-7605
Last Modified:
5/3/2006
10.
Phase II Adjuvant Chemotherapy with CLZ, TZT, CACP, or BCNU/5-FU for Intracranial Neoplasms
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 15
BTSG-7820
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute